As per NPPA Order S.O. 5690(E) dated 17 October 2026, the trade margin on 137 non-scheduled anti-cancer medicines is capped at 30%. Hetero’s revised MRPs take effect on 9 November 2026.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
Frenza Division specialises in women's healthcare and paediatric care, offering a broad range of solutions for pregnancy management, vaginal wellness, nutritional support, paediatric, respiratory health, and gastrointestinal care. This division combines scientific expertise with high-quality formulations to support improved patient outcomes. With a strong emphasis on quality, innovation, and patient well-being, Frenza delivers reliable therapeutic solutions that help healthcare professionals provide effective care for mothers and children.
View by-